GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Shiller PE Ratio
中文

Novartis AG (Novartis AG) Shiller PE Ratio

: 15.87 (As of Today)
View and export this data going back to 1996. Start your Free Trial

As of today (2024-04-24), Novartis AG's current share price is $97.58. Novartis AG's E10 for the quarter that ended in Dec. 2023 was $6.15. Novartis AG's Shiller PE Ratio for today is 15.87.

The historical rank and industry rank for Novartis AG's Shiller PE Ratio or its related term are showing as below:

NVS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.78   Med: 16.91   Max: 21.68
Current: 17.27

During the past years, Novartis AG's highest Shiller PE Ratio was 21.68. The lowest was 12.78. And the median was 16.91.

NVS's Shiller PE Ratio is ranked better than
70.82% of 514 companies
in the Drug Manufacturers industry
Industry Median: 24.405 vs NVS: 17.27

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis AG's adjusted earnings per share data for the three months ended in Dec. 2023 was $4.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $6.15 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novartis AG Shiller PE Ratio Historical Data

The historical data trend for Novartis AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.84 19.66 16.02 16.45 16.42

Novartis AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.45 16.22 17.37 18.16 16.42

Competitive Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Shiller PE Ratio falls into.



Novartis AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis AG's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=97.58/6.15
=15.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Novartis AG's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=4.06/106.4611*106.4611
=4.060

Current CPI (Dec. 2023) = 106.4611.

Novartis AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 1.190 101.224 1.252
201406 1.030 101.517 1.080
201409 1.310 101.247 1.377
201412 0.610 100.704 0.645
201503 5.320 100.339 5.645
201506 0.750 100.464 0.795
201509 0.770 99.785 0.822
201512 0.440 99.386 0.471
201603 0.840 99.475 0.899
201606 0.750 100.088 0.798
201609 0.810 99.604 0.866
201612 0.400 99.380 0.429
201703 0.700 100.040 0.745
201706 0.830 100.285 0.881
201709 0.880 100.254 0.934
201712 0.840 100.213 0.892
201803 0.860 100.836 0.908
201806 3.310 101.435 3.474
201809 0.690 101.246 0.726
201812 0.510 100.906 0.538
201903 0.760 101.571 0.797
201906 2.910 102.044 3.036
201909 0.890 101.396 0.934
201912 0.490 101.063 0.516
202003 0.950 101.048 1.001
202006 0.810 100.743 0.856
202009 0.840 100.585 0.889
202012 0.920 100.241 0.977
202103 0.910 100.800 0.961
202106 1.280 101.352 1.345
202109 1.220 101.533 1.279
202112 7.240 101.776 7.573
202203 0.990 103.205 1.021
202206 0.770 104.783 0.782
202209 0.720 104.835 0.731
202212 0.680 104.666 0.692
202303 1.080 106.245 1.082
202306 1.110 106.576 1.109
202309 0.850 106.570 0.849
202312 4.060 106.461 4.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novartis AG  (NYSE:NVS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novartis AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novartis AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (Novartis AG) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.